# Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).

> **NCT03684122** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Jordan** · enrollment: 10 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **BIOLOGICAL:** Injection of Umbilical cord derived MSCs

## Key facts

- **NCT ID:** NCT03684122
- **Lead sponsor:** University of Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-09-20
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03684122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03684122, "Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03684122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*